These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2627754)

  • 21. [Erythrocyte sodium transport in children with pseudohypoaldosteronism].
    Uchiyama M; Gomi T; Satokata I; Sakai K
    Rinsho Byori; 1988 Jun; 36(6):685-8. PubMed ID: 3210317
    [No Abstract]   [Full Text] [Related]  

  • 22. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
    Hanukoglu A
    J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
    Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extrarenal receptor-effector-mechanisms for aldosterone: the sequence of effects on the cellular electrolyte transport in human lymphocytes and their implications for disorders of the water and electrolyte balances.
    Wehling M; Theisen K
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):385-94. PubMed ID: 2146852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pseudohypoaldosteronism: options for consideration.
    Komesaroff PA
    Steroids; 1995 Jan; 60(1):168-72. PubMed ID: 7792807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Soubrier F
    J Clin Endocrinol Metab; 1994 Jul; 79(1):32-8. PubMed ID: 8027248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudohypoaldosteronism in a female infant and her family: diversity of clinical expression and mode of inheritance.
    Chitayat D; Spirer Z; Ayalon D; Golander A
    Acta Paediatr Scand; 1985 Jul; 74(4):619-22. PubMed ID: 4024936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fast effects of aldosterone on electrolytes in human lymphocytes are mediated by the sodium-proton-exchanger of the cell membrane.
    Wehling M; Käsmayr J; Theisen K
    Biochem Biophys Res Commun; 1989 Nov; 164(3):961-7. PubMed ID: 2556129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of mineralocorticoid-resistant renal hyperkalemia without sodium wasting (type II pseudohypoaldosteronism)].
    Ito K; Yamada K; Hasunuma K; Shiina T; Ebata T; Kikuno K; Yoshida S; Tamura Y; Yoshida S
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):425-9. PubMed ID: 3042897
    [No Abstract]   [Full Text] [Related]  

  • 33. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
    Loomba-Albrecht LA; Nagel M; Bremer AA
    Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
    Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
    J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism.
    Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Corvol P; Soubrier F
    Steroids; 1995 Jan; 60(1):164-7. PubMed ID: 7792806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aldosterone on intralymphocytic sodium and potassium in patients with primary aldosteronism.
    Wehling M; Kuhls S; Witzgall H; Kuhnle U; Armanini D; Theisen K
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):555-60. PubMed ID: 3425166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume regulation of human lymphocytes by aldosterone in isotonic media.
    Wehling M; Kuhls S; Armanini D
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E170-4. PubMed ID: 2764099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineralocorticoid effector mechanism of liquorice derivatives in human mononuclear leukocytes.
    Armanini D; Wehling M; Weber PC
    J Endocrinol Invest; 1989 May; 12(5):303-6. PubMed ID: 2549114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 pseudohypoaldosteronism: new insights into renal potassium, sodium, and chloride handling.
    Proctor G; Linas S
    Am J Kidney Dis; 2006 Oct; 48(4):674-93. PubMed ID: 16997066
    [No Abstract]   [Full Text] [Related]  

  • 40. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.